Return on Assets (ROA)
since 2012
Difficulty: Beginner
Calculation
AbbVie Inc., ROA, long-term trends, calculation
| ROA | = | 100 | × | Net earnings1 | ÷ | Total assets1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2012 | 19.53% | = | 100 | × | 5,275 | ÷ | 27,008 |
| Dec 31, 2013 | 14.14% | = | 100 | × | 4,128 | ÷ | 29,198 |
| Dec 31, 2014 | 6.44% | = | 100 | × | 1,774 | ÷ | 27,547 |
| Dec 31, 2015 | 9.70% | = | 100 | × | 5,144 | ÷ | 53,050 |
| Dec 31, 2016 | 9.01% | = | 100 | × | 5,953 | ÷ | 66,099 |
| Dec 31, 2017 | 7.50% | = | 100 | × | 5,309 | ÷ | 70,786 |
1 USD $ in millions
Source: Based on data from AbbVie Inc. Annual Reports
Comparison to Competitors
AbbVie Inc., ROA, long-term trends, comparison to competitors
| AbbVie Inc. | Abbott Laboratories | Allergan PLC | Amgen Inc. | Biogen Inc. | Bristol-Myers Squibb Co. | Celgene Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2012 | 19.53% | 8.87% | 0.69% | 8.00% | 13.62% | 5.46% | 12.41% | 11.89% | 12.20% | 8.94% | 5.81% | 7.84% | 36.06% |
| Dec 31, 2013 | 14.14% | 6.00% | -3.30% | 7.68% | 15.70% | 6.64% | 10.84% | 13.29% | 13.67% | 10.42% | 4.17% | 12.78% | 14.38% |
| Dec 31, 2014 | 6.44% | 5.53% | -3.10% | 7.47% | 20.50% | 5.94% | 11.53% | 6.43% | 34.91% | 12.45% | 12.12% | 5.40% | 8.99% |
| Dec 31, 2015 | 9.70% | 10.72% | 2.88% | 9.69% | 18.19% | 4.93% | 5.92% | 6.77% | 34.93% | 11.55% | 4.36% | 4.16% | 11.34% |
| Dec 31, 2016 | 9.01% | 2.66% | 11.61% | 9.95% | 16.19% | 13.22% | 7.12% | 7.05% | 23.70% | 11.71% | 4.11% | 4.20% | 12.84% |
| Dec 31, 2017 | 7.50% | 0.63% | -3.49% | 2.48% | 10.73% | 3.00% | 9.75% | -0.45% | 6.58% | 0.83% | 2.72% | 12.40% | 13.67% |
Source: Based on data from AbbVie Inc. Annual Reports
Comparison to Pharmaceuticals & Biotechnology Sector
AbbVie Inc., ROA, long-term trends, comparison to Pharmaceuticals & Biotechnology sector
| AbbVie Inc. | Pharmaceuticals & Biotechnology | |
|---|---|---|
| Dec 31, 2012 | 19.53% | 8.61% |
| Dec 31, 2013 | 14.14% | 9.39% |
| Dec 31, 2014 | 6.44% | 9.14% |
| Dec 31, 2015 | 9.70% | 8.58% |
| Dec 31, 2016 | 9.01% | 9.23% |
| Dec 31, 2017 | 7.50% | 4.19% |
Source: Based on data from AbbVie Inc. Annual Reports
Comparison to Health Care Industry
AbbVie Inc., ROA, long-term trends, comparison to Health Care industry
| AbbVie Inc. | Health Care | |
|---|---|---|
| Dec 31, 2012 | 19.53% | 8.01% |
| Dec 31, 2013 | 14.14% | 8.60% |
| Dec 31, 2014 | 6.44% | 8.24% |
| Dec 31, 2015 | 9.70% | 7.43% |
| Dec 31, 2016 | 9.01% | 8.14% |
| Dec 31, 2017 | 7.50% | 4.69% |
Source: Based on data from AbbVie Inc. Annual Reports